NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What are the components of the PEP regimen?

Truvada + Raltegravir
Abacavir/Lamivudine + Raltegravir
Truvada + Darunavir
Descovy + Raltegravir

The correct answer is: Truvada + Raltegravir

The correct answer is A. Truvada + Raltegravir are the components of the PEP (post-exposure prophylaxis) regimen for HIV. Truvada is a combination medication containing emtricitabine and tenofovir disoproxil fumarate, which are both antiretroviral drugs. Raltegravir is an integrase inhibitor that helps prevent the replication of HIV. Option B, Abacavir/Lamivudine + Raltegravir, is not a correct combination for PEP. Abacavir and lamivudine are commonly used together as part of the treatment of HIV, but they are not recommended as a PEP regimen. Option C, Truvada + Darunavir, includes Truvada, which is correct, but Darunavir is not typically used in PEP regimens. Darunavir is a protease inhibitor that is more commonly used in the treatment of HIV rather than for post-exposure prophylaxis. Option D, Descovy + Raltegravir, includes Raltegravir, which is a component of the PEP regimen. However, Descovy is not generally part of the PEP regimen. Descovy is another combination medication similar to Truvada but contains a newer form of tenofovir called tenofovir alafenamide.